216 related articles for article (PubMed ID: 26084043)
1. Human Gingival Integration-Free iPSCs; a Source for MSC-Like Cells.
Umezaki Y; Hashimoto Y; Nishishita N; Kawamata S; Baba S
Int J Mol Sci; 2015 Jun; 16(6):13633-48. PubMed ID: 26084043
[TBL] [Abstract][Full Text] [Related]
2. Generation and periodontal differentiation of human gingival fibroblasts-derived integration-free induced pluripotent stem cells.
Yin X; Li Y; Li J; Li P; Liu Y; Wen J; Luan Q
Biochem Biophys Res Commun; 2016 May; 473(3):726-32. PubMed ID: 26456649
[TBL] [Abstract][Full Text] [Related]
3. Gingival Fibroblasts as Autologous Feeders for Induced Pluripotent Stem Cells.
Yu G; Okawa H; Okita K; Kamano Y; Wang F; Saeki M; Yatani H; Egusa H
J Dent Res; 2016 Jan; 95(1):110-8. PubMed ID: 26467419
[TBL] [Abstract][Full Text] [Related]
4. Derivation, Expansion, and Motor Neuron Differentiation of Human-Induced Pluripotent Stem Cells with Non-Integrating Episomal Vectors and a Defined Xenogeneic-free Culture System.
Hu W; He Y; Xiong Y; Lu H; Chen H; Hou L; Qiu Z; Fang Y; Zhang S
Mol Neurobiol; 2016 Apr; 53(3):1589-1600. PubMed ID: 25663198
[TBL] [Abstract][Full Text] [Related]
5. An efficient nonviral method to generate integration-free human-induced pluripotent stem cells from cord blood and peripheral blood cells.
Okita K; Yamakawa T; Matsumura Y; Sato Y; Amano N; Watanabe A; Goshima N; Yamanaka S
Stem Cells; 2013 Mar; 31(3):458-66. PubMed ID: 23193063
[TBL] [Abstract][Full Text] [Related]
6. Isolation and characterization of mesenchymal stem cell-like cells from healthy and inflamed gingival tissue: potential use for clinical therapy.
Ge S; Mrozik KM; Menicanin D; Gronthos S; Bartold PM
Regen Med; 2012 Nov; 7(6):819-32. PubMed ID: 23164082
[TBL] [Abstract][Full Text] [Related]
7. Induction of pluripotency in human umbilical cord mesenchymal stem cells in feeder layer-free condition.
Daneshvar N; Rasedee A; Shamsabadi FT; Moeini H; Mehrboud P; Rahman HS; Boroojerdi MH; Vellasamy S
Tissue Cell; 2015 Dec; 47(6):575-82. PubMed ID: 26471847
[TBL] [Abstract][Full Text] [Related]
8. Immunomodulatory Properties of Induced Pluripotent Stem Cell-Derived Mesenchymal Cells.
Ng J; Hynes K; White G; Sivanathan KN; Vandyke K; Bartold PM; Gronthos S
J Cell Biochem; 2016 Dec; 117(12):2844-2853. PubMed ID: 27167148
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the characteristics of mesenchymal stem-like cells derived by integration-free induced pluripotent stem cells in different single-cell culture media under feeder-free conditions.
Ueda M; Hashimoto Y; Honda Y; Baba S; Morita S
Med Mol Morphol; 2019 Sep; 52(3):147-155. PubMed ID: 30446810
[TBL] [Abstract][Full Text] [Related]
10. Induced pluripotent stem cells from human placental chorion for perinatal tissue engineering applications.
Jiang G; Di Bernardo J; DeLong CJ; Monteiro da Rocha A; O'Shea KS; Kunisaki SM
Tissue Eng Part C Methods; 2014 Sep; 20(9):731-40. PubMed ID: 24447109
[TBL] [Abstract][Full Text] [Related]
11. Patient-tailored application for Duchene muscular dystrophy on mdx mice based induced mesenchymal stem cells.
Jeong J; Shin K; Lee SB; Lee DR; Kwon H
Exp Mol Pathol; 2014 Oct; 97(2):253-8. PubMed ID: 25102299
[TBL] [Abstract][Full Text] [Related]
12. Generation, Characterization, and Multilineage Potency of Mesenchymal-Like Progenitors Derived from Equine Induced Pluripotent Stem Cells.
Lepage SI; Nagy K; Sung HK; Kandel RA; Nagy A; Koch TG
Stem Cells Dev; 2016 Jan; 25(1):80-9. PubMed ID: 26414480
[TBL] [Abstract][Full Text] [Related]
13. Generation and differentiation of induced pluripotent stem cells reveal ankylosing spondylitis risk gene expression in bone progenitors.
Layh-Schmitt G; Lu S; Navid F; Brooks SR; Lazowick E; Davis KM; Montagna C; Gadina M; Colbert RA
Clin Rheumatol; 2017 Jan; 36(1):143-154. PubMed ID: 27864696
[TBL] [Abstract][Full Text] [Related]
14. Osteopetrotic induced pluripotent stem cells derived from patients with different disease-associated mutations by non-integrating reprogramming methods.
Okur FV; Cevher İ; Özdemir C; Kocaefe Ç; Çetinkaya DU
Stem Cell Res Ther; 2019 Jul; 10(1):211. PubMed ID: 31315669
[TBL] [Abstract][Full Text] [Related]
15. Modeling of hemophilia A using patient-specific induced pluripotent stem cells derived from urine cells.
Jia B; Chen S; Zhao Z; Liu P; Cai J; Qin D; Du J; Wu C; Chen Q; Cai X; Zhang H; Yu Y; Pei D; Zhong M; Pan G
Life Sci; 2014 Jul; 108(1):22-9. PubMed ID: 24834837
[TBL] [Abstract][Full Text] [Related]
16. Derivation of murine induced pluripotent stem cells (iPS) and assessment of their differentiation toward osteogenic lineage.
Li F; Bronson S; Niyibizi C
J Cell Biochem; 2010 Mar; 109(4):643-52. PubMed ID: 20039314
[TBL] [Abstract][Full Text] [Related]
17. Generation and characterization of integration-free induced pluripotent stem cells from patients with autoimmune disease.
Son MY; Lee MO; Jeon H; Seol B; Kim JH; Chang JS; Cho YS
Exp Mol Med; 2016 May; 48(5):e232. PubMed ID: 27174201
[TBL] [Abstract][Full Text] [Related]
18. Generation of Footprint-Free Induced Pluripotent Stem Cells from Human Fibroblasts Using Episomal Plasmid Vectors.
Ovchinnikov DA; Sun J; Wolvetang EJ
Methods Mol Biol; 2015; 1330():37-45. PubMed ID: 26621587
[TBL] [Abstract][Full Text] [Related]
19. Functional mesenchymal stem cells derived from human induced pluripotent stem cells attenuate limb ischemia in mice.
Lian Q; Zhang Y; Zhang J; Zhang HK; Wu X; Zhang Y; Lam FF; Kang S; Xia JC; Lai WH; Au KW; Chow YY; Siu CW; Lee CN; Tse HF
Circulation; 2010 Mar; 121(9):1113-23. PubMed ID: 20176987
[TBL] [Abstract][Full Text] [Related]
20. Production of functional coagulation factor VIII from iPSCs using a lentiviral vector.
Kashiwakura Y; Ohmori T; Mimuro J; Madoiwa S; Inoue M; Hasegawa M; Ozawa K; Sakata Y
Haemophilia; 2014 Jan; 20(1):e40-4. PubMed ID: 24354485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
